Neuroprotective activities of CEP-1347 in models of neuroAIDS. - Wikidata - wikimedia - TriplyDB

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

http://www.wikidata.org/entity/Q33587971

about

c-Jun N-Terminal Phosphorylation: Biomarker for Cellular Stress Rather than Cell Death in the Injured Cochlea.Neural correlates of working memory training in HIV patients: study protocol for a randomized controlled trial.Cognitive Consequences of Aging with HIV: Implications for Neuroplasticity and Rehabilitation.IFNβ Protects Neurons from Damage in a Murine Model of HIV-1 Associated Brain Injury Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3.HIV-1 neuroimmunity in the era of antiretroviral therapy.Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders.Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS Rodent models for HIV-associated neurocognitive disorders.Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis Lipid rafts and functional caveolae regulate HIV-induced amyloid beta accumulation in brain endothelial cells.Assessing and treating forgetfulness and cognitive problems in adults with HIV Mitogen-activated protein kinase p38 in HIV infection and associated brain injury.Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patients.The role of neuroplasticity and cognitive reserve in aging with HIV: recommendations for cognitive protection and rehabilitation.Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase Neuropharmacologic Approaches to Restore the Brain's Microenvironment.Humanized mice: models for evaluating NeuroHIV and cure strategies.Commentary: Animal models of neuroAIDS.Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson's disease, as an anti-cancer stem cell drug.Marine-derived protein kinase inhibitors for neuroinflammatory diseases.

P2860

Q30382124-37E93169-788A-4B63-A5C9-12D87CC08D77 Q30391907-A965A2ED-DD90-42D9-B021-1A9D840032F7 Q33579178-9AF0D06E-CD7D-432D-96DC-FA1CD6DA4ACE Q33582709-DB905762-14B8-4D21-AC75-D8DA60E7597F Q33654498-D8FEDD49-7C35-4D9C-9A50-098457DBC4EF Q33733529-2F5DD392-D5A6-454F-A42A-D2355178831C Q34358241-82F863C4-C077-4ECD-8D44-535BC65751A7 Q34507098-4E6CCA3E-5F58-4B36-AB29-54CA3C89F687 Q34769218-757FDC9F-3974-4FB1-8C17-E667DB8187D0 Q35028750-165F44E0-5392-4F0C-A97F-706A89F50BED Q35803957-10BBE21D-BD58-425C-98E8-94033B99CD68 Q35921136-79E58AB9-956E-4AC0-9D14-6BB4D958F0DC Q35947300-A8FE7515-4BB4-4EA3-A957-5CC57CB89837 Q36666859-F0A9ACF9-B4C1-4B87-B23D-796DA97FA8D4 Q36950000-B262E819-C958-4B3F-B9A8-E019DCE3AC6B Q36950047-1BBEC4F7-C8B2-4FA4-B7AD-1E6B0536BF8C Q37140177-E9C22F00-16FD-4357-BB65-FBB855E6F64F Q37169223-45A4D271-2451-4F2B-8A65-939CF4B29D20 Q37794385-7F53812F-20EC-487A-895B-ACDA70436787 Q38879533-F01A7BE3-E36D-49BF-A6DC-8667A3CFF002 Q40074303-739CBD52-D24C-4A91-95B6-DA8D023290EC Q41850246-32B9297E-C7CB-4952-A476-18F94B2FA02F Q47136172-22656A57-6837-45F7-8164-5555522A0E8E Q52565796-CDBB9DEC-8910-413C-B42A-3117002AC8E0

P2860

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

http://www.wikidata.org/entity/Q33587971

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

@ast

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

@en

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

@nl

type

label

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

@ast

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

@en

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

@nl

prefLabel

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

@ast

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

@en

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

@nl

P1433

Q33587971-9FE9DC0A-E3E2-4FFD-BDD7-466391E66B85

P1476

Q33587971-D74752B4-5C27-425C-996F-15ACBB19F6B7

P2093

Q33587971-506F70CF-296A-4865-B361-203FFCAD933E

Q33587971-5EFB70CD-EA66-4B2A-83B5-A5A8A3F9669B

Q33587971-62FB3F24-5303-4A74-90EF-D82E46F2A365

Q33587971-74CB8890-8D1A-420A-9EA9-53080AAE98B2

Q33587971-9C4FD67A-CB69-432A-95AC-D9D48CC88E12

Q33587971-B183EE3D-38D3-4383-BA2E-774E854E5F1E

Q33587971-EEBA4880-4964-4767-91CF-29304CDD0714

P2860

Q33587971-00E10854-4212-48F6-8CA1-34931D87190B

Q33587971-0C1B7A74-0B8B-4B51-9643-1A25430EE468

Q33587971-0E15778E-2BD1-443E-BD13-DA7C38A91D74

Q33587971-12EB579A-18B9-402E-B312-73D32FCC1077

Q33587971-1A9A934F-2DC6-4E04-B5A5-94C7FF51F59D

Q33587971-26F1D582-B873-4CB0-A17A-1BA2D429FF1E

Q33587971-3A72C455-3A95-4E29-9DE1-9890E443C62C

Q33587971-3F40C691-31EF-441D-B483-013CA9E859C1

Q33587971-41974FE4-4070-4E4A-90A5-FDD043EC8198

Q33587971-463D67B4-2AB0-40C4-9475-AD527328CB54

P304

Q33587971-9BD017D0-C8AF-4C53-9B73-0E0C80414B7E

P31

Q33587971-0D409ECD-335F-472B-B888-0E4BCD7E01F0

P356

Q33587971-75241E42-CCC8-4453-95AD-7ABA65DCB30B

P407

Q33587971-9ED99354-DEBA-452D-959C-E3C8611E07FD

P433

Q33587971-02485C11-7763-41C5-9112-A3FEC14ADED7

P478

Q33587971-C34A321B-E1F1-4E69-A566-13C6B9862675

P50

Q33587971-4E4D47BE-79F9-40DF-9B2B-F3768E49C17A

Q33587971-8897FE80-FF71-4D19-A937-7061045732F2

Q33587971-BDF6B087-4CFD-440A-80A2-CFEDFE4CD1F9

P577

Q33587971-E4060361-97DD-4A8A-A07E-43915517BFC3

P5875

Q33587971-0F005309-65F3-4CF4-9301-D2C951E3DA0A

P698

Q33587971-A5BD2D26-A339-46DE-8369-C759E4CF6F40

P932

Q33587971-40D18340-68BA-40FA-B314-4A895E26AFC3

P356

JIMMUNOL.0902962

P1433

Journal of Immunology

P1476

Neuroprotective activities of CEP-1347 in models of neuroAIDS.

@en

P2093

Dawn Eggert

http://www.w3.org/2001/XMLSchema#string

Giovanni Schifitto

http://www.w3.org/2001/XMLSchema#string

Howard E Gendelman

http://www.w3.org/2001/XMLSchema#string

Huanyu Dou

http://www.w3.org/2001/XMLSchema#string

Prasanta K Dash

http://www.w3.org/2001/XMLSchema#string

Sanjay B Maggirwar

http://www.w3.org/2001/XMLSchema#string

Santhi Gorantla

http://www.w3.org/2001/XMLSchema#string

P2860

Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons

Human microglia convert l-tryptophan into the neurotoxin quinolinic acid

Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38

An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis.

Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis.

Identification of novel therapeutic targets for HIV infection through functional genomic cDNA screening.

HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions.

Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia

HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia.

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

P304

746-756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0902962

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P50

Larisa Poluektova

Stephen Dewhurst

Harris A Gelbard

P577

2009-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40453168

http://www.w3.org/2001/XMLSchema#string

P698

19966207

http://www.w3.org/2001/XMLSchema#string

P932

2805820

http://www.w3.org/2001/XMLSchema#string